Gilead Sciences Balance Sheet Health
Financial Health criteria checks 4/6
Gilead Sciences has a total shareholder equity of $22.7B and total debt of $25.0B, which brings its debt-to-equity ratio to 109.8%. Its total assets and total liabilities are $62.1B and $39.4B respectively. Gilead Sciences's EBIT is $9.8B making its interest coverage ratio 17.3. It has cash and short-term investments of $8.4B.
Key information
109.8%
Debt to equity ratio
US$24.99b
Debt
Interest coverage ratio | 17.3x |
Cash | US$8.35b |
Equity | US$22.75b |
Total liabilities | US$39.38b |
Total assets | US$62.13b |
Recent financial health updates
These 4 Measures Indicate That Gilead Sciences (NASDAQ:GILD) Is Using Debt Reasonably Well
Nov 17We Think Gilead Sciences (NASDAQ:GILD) Can Stay On Top Of Its Debt
Aug 11Recent updates
Gilead Sciences: Realizing Financial Projections Is Key
Mar 20Gilead Sciences' (NASDAQ:GILD) Dividend Will Be Increased To $0.77
Mar 13Gilead's Business Development: The Good, The Bad, And The Spinning Kite Solution
Mar 01Gilead Sciences (NASDAQ:GILD) Has Announced That It Will Be Increasing Its Dividend To $0.77
Feb 28We Think Gilead Sciences' (NASDAQ:GILD) Solid Earnings Are Understated
Feb 15Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.77
Feb 13Gilead Sciences: Cheap For A Reason
Feb 10Gilead Sciences: The Sky Is Not Falling
Feb 01Does Gilead Sciences (NASDAQ:GILD) Deserve A Spot On Your Watchlist?
Jan 15What Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is Not Telling You
Dec 25These 4 Measures Indicate That Gilead Sciences (NASDAQ:GILD) Is Using Debt Reasonably Well
Nov 17Does Gilead Sciences (NASDAQ:GILD) Deserve A Spot On Your Watchlist?
Oct 10We Think Gilead Sciences (NASDAQ:GILD) Can Stay On Top Of Its Debt
Aug 11Here's Why Gilead Sciences (NASDAQ:GILD) Has Caught The Eye Of Investors
Jul 04Gilead Sciences (NASDAQ:GILD) Is Paying Out A Larger Dividend Than Last Year
Jun 13Financial Position Analysis
Short Term Liabilities: GILD's short term assets ($16.1B) exceed its short term liabilities ($11.3B).
Long Term Liabilities: GILD's short term assets ($16.1B) do not cover its long term liabilities ($28.1B).
Debt to Equity History and Analysis
Debt Level: GILD's net debt to equity ratio (73.1%) is considered high.
Reducing Debt: GILD's debt to equity ratio has reduced from 126.9% to 109.8% over the past 5 years.
Debt Coverage: GILD's debt is well covered by operating cash flow (32%).
Interest Coverage: GILD's interest payments on its debt are well covered by EBIT (17.3x coverage).